Breakthrough in Acid Reflux Disease Management: Novel Bioelectronic Stent Offers Real-time Intervention

Strategic Insights -

A team of researchers from Xiangya Hospital has developed a non-invasive, closed-loop bioelectronic stent to manage gastroesophageal reflux disease (GERD). This innovative technology enables real-time intervention to prevent disease progression and improve long-term outcomes. According to the study, the stent achieves 99.7% accuracy in reflux episode detection and successfully induces sphincter contraction in more than 95% of events. This breakthrough has significant implications for the management of GERD, a prevalent chronic condition affecting approximately 33% of the population and increasing the risk of esophageal cancer.

Key Takeaways:

  • The novel bioelectronic stent is a non-invasive, closed-loop device that enables real-time management of GERD without disrupting normal esophageal function.
  • The stent integrates vertically aligned multiple-channel pH/impedance fiber sensors for reflux detection and an electrical stimulator with pressure feedback.
  • In GERD animal models, the stent achieved 99.7% accuracy in reflux episode detection and successfully induced sphincter contraction in more than 95% of events.
  • The stent's shape-memory properties and low modulus allow for synchronized operation with esophageal motility without affecting physiological function.
  • This technology offers a novel solution for GERD management with real-time intervention for preventing disease progression and improving long-term outcomes.
  • The stent was developed using an industrial weaving machine with functionalized fibers, followed by electroplating and chemical etching.
  • The study's findings demonstrate the potential of bioelectronic stents in managing GERD and potentially reducing the risk of esophageal cancer.
  • The research was supported by the National Natural Science Foundation of China (NSFC) and the Science & Technology Commission of Shanghai Municipality (STCSM).

Statistics:

  • Approximately 33% of the population is affected by GERD.
  • The incidence of GERD increases the risk of esophageal cancer by [specific percentage].
  • The novel bioelectronic stent achieves 99.7% accuracy in reflux episode detection.
  • The stent successfully induces sphincter contraction in more than 95% of events.
  • The stent's operation does not disrupt normal esophageal function.

Sources:

  • NewsRx. Findings from Xiangya Hospital Provides New Data about Acid Reflux Disease (A Non-invasive, Closed-loop Electronic Stent for Real-time Management of Gastroesophageal Reflux Disease). Cancer Weekly. November 4, 2025; p 991.
  • Xiangya Hospital research team. A Non-invasive, Closed-loop Electronic Stent for Real-time Management of Gastroesophageal Reflux Disease. Advanced Fiber Materials, 2025.